A conceptual framework for the use of neuroimaging to study and predict pharmacoresistance in epilepsy.

Epilepsia

Volumn 54 Suppl 2, Issue , 2013, Pages 75-79

  Pohlmann Eden, Bernd ^a   Crocker, Candice E ^b   Schmidt, Matthias H ^b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT;

COHORT ANALYSIS; DRUG RESISTANCE; EPILEPSY; HUMAN; NEUROIMAGING; PATHOPHYSIOLOGY; PATIENT SELECTION; PHYSIOLOGY; PREDICTIVE VALUE; REVIEW; UTILIZATION REVIEW;

ANTICONVULSANTS; COHORT STUDIES; DRUG RESISTANCE; EPILEPSY; HUMANS; NEUROIMAGING; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS;

MLCS; MLOWN;

EID: 84880503687     PISSN: None     EISSN: 15281167     Source Type: None    
DOI: 10.1111/epi.12190     Document Type: Review

References (0)